The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells

AUTOR(ES)

Klejman, Agata

FONTE

Oxford University Press

RESUMO

Signal transducer and activator of transcription 5 (STAT5) is constitutively activated by BCR/ABL, the oncogenic tyrosine kinase responsible for chronic myelogenous leukemia. The mechanism of BCR/ABL-mediated STAT5 activation is unknown. We show here that the BCR/ABL SH3 and SH2 domains interact with hematopoietic cell kinase (Hck), leading to the stimulation of Hck catalytic activity. Active Hck phosphorylated STAT5B on Tyr699, which represents an essential step in STAT5B stimulation. Moreover, a kinase-dead Hck mutant and Hck inhibitor PP2 abrogated BCR/ABL-dependent activation of STAT5 and elevation of expression of STAT5 downstream effectors A1 and pim-1. These data identify a novel BCR/ABL–Hck–STAT5 signaling pathway, which plays an important role in BCR/ABL-mediated transformation of myeloid cells.

Documentos Relacionados

• Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias
• Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation
• Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
• Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
• bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.